Charles Feldman to Fluoroquinolones
This is a "connection" page, showing publications Charles Feldman has written about Fluoroquinolones.
Connection Strength
1,483
-
Rational use of the fluoroquinolones. S Afr Med J. 2019 May 31; 109(6):378-381.
Score: 0,650
-
Antimicrobial susceptibility of pneumococcal isolates causing bacteraemic pneumococcal pneumonia: analysis using current breakpoints and fluoroquinolone pharmacodynamics. Int J Antimicrob Agents. 2010 Jul; 36(1):95-7.
Score: 0,345
-
Gemifloxacin once daily for 7 days compared to amoxicillin/clavulanic acid thrice daily for 10 days for the treatment of community-acquired pneumonia of suspected pneumococcal origin. Respir Med. 2004 Aug; 98(8):708-20.
Score: 0,233
-
An open, randomised, multi-centre study comparing the safety and efficacy of sitafloxacin and imipenem/cilastatin in the intravenous treatment of hospitalised patients with pneumonia. Int J Antimicrob Agents. 2001 Mar; 17(3):177-88.
Score: 0,183
-
Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin by Streptococcus pneumoniae in vitro. J Antimicrob Chemother. 2007 Nov; 60(5):1155-8.
Score: 0,072